trophogen, inc. is a biotechnology company founded in 2001, focusing on the development of high affinity glycoprotein hormone and related growth factor analogs for targeted therapy and imaging of ovarian, breast, prostate, testicular and thyroid cancers as well as for human and animal infertility.

Cancer Ovarian Cancer Ovary Cancer Thyroid Cancer Prostate Cancer Testicular Cancer Brest Cancer Anti Cancer Drugs Cancer Treatment Cancer Targeting Cancer Visualisation Cancer Imaging Superactive Analogs Glycoprotein Hormones Super Active Hormones Protein Analogs Superagonists Protein Therapeutics Drug Discovery Rational Drug Design Growth Factors Gonadotropins Cystine Knot Growth Factors Recombinant Hormones Enhancing Nature Biotechnology Maryland Biotech

Hormone Evolution Electrostatic Interactions In Hormones Thyrogen Thyroid Stimulating Hormone Follicle Stimulating Hormone Luteinizing Hormone Start-up Biotech Infertility Drugs Recombinant Glycoproteins In Vitro Fertilization Fertility Hormones Protein Evolution Protein Technology Private Sector Biotechnology Structure-function Studies Recombinant Tsh Recombinant Fsh Recombinant Lh Superactive Analogs Glycoprotein Engineering Hormone Engineering Glycoprotein Analogs Protein Engineering Local Biotechnology Nih License Trophogen Rockville Biotech

Contact:	301-838-1935 x101
Address:	6 Taft Ct Ste 150, Rockville, Maryland   20850-5361 , USA
Url:	http://www.trophogen.com
Fax:	301-762-6287
Year Established:	2001